UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | V | W | Z
Number of items: 215.

A

ALLAIN, J; HEWITT, P; TEDDER, RS; WILLIAMSON, LM; (1999) Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. British Journal of Haematology , 107 pp. 186-195.

Ahmed, Y; Mwaba, P; Chintu, C; Grange, JM; Ustianowski, A; Zumla, A; (1999) A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. INT J TUBERC LUNG D , 3 (8) 675 - 680.

Aicher, WK; Dinkel, A; Grimbacher, B; Haas, C; von Seydlitz-Kurzbach, E; Peter, HH; Eibel, H; (1999) Serum response elements activate and cAMP responsive elements inhibit expression of transcription factor Egr-1 in synovial fibroblasts of rheumatoid arthritis patients. INT IMMUNOL , 11 (1) 47 - 61.

Aitken, C; Barrett-Muir, W; Millar, C; Templeton, K; Thomas, J; Sheridan, F; Jeffries, D; (1999) Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation. J CLIN MICROBIOL , 37 (9) 2804 - 2807.

Aitken, C; Barrett-Muir, W; Raftery, M; Breuer, J; (1999) The clinical significance of ganciclovir resistance in a renal transplant patient. NEPHROL DIAL TRANSPL , 14 (4) 1050 - 1051.

Aitken, C; Hawrami, K; Miller, C; Muir, WB; Yaqoob, M; Breuer, J; (1999) Simultaneous treatment of cytomegalovirus and varicella zoster infections in a renal transplant recipient with ganciclovir: Use of viral load to monitor response to treatment. J MED VIROL , 59 (3) 412 - 414.

Andersson, J; Nilsson, J; Perrin, L; Kinloch, S; Tyrer, M; Gazzard, B; Stellbrink, H; (1999) Imbalance of cytokine effector molecules in CD8+ in lymphoid tissue during primary HIV infection (PHI). Presented at: 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California.

Andersson, J; Racz, P; Tenner-Racz, K; Stellbrink, HJ; Kinloch, S; Janossy, G; Tyrer, M; (1999) Defect in cytolytic effector molecules in lymphoid tissue during primary HIV infection (PHI) is a very early mechanism of immune dysfunction. Presented at: 6th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, USA.

Andersson, J; Racz, P; Tenner-Racz, K; Stellbrink, HJ; Kinloch, S; Janossy, G; Tyrer, M; (1999) Potent and aberrant CD4 responses in lymphoid tissue during primary HIV infection. Presented at: 6th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, USA.

Aosai, F; Mun, HS; Norose, K; Chen, M; Hata, H; Kobayashi, M; Kiuchi, M; (1999) Protective immunity induced by vaccination with SAG1 gene-transfected cells against Toxoplasma gondii-infection in mice. MICROBIOL IMMUNOL , 43 (1) 87 - 91.

B

Baboo, KS; Luo, NP; Murphy, JR; Cummings, C; Chintu, C; Ustianowski, A; DuPont, HL; (1999) HIV-1 seroprevalence in Zambian patients with acute diarrhea: A community-based study. J ACQ IMMUN DEF SYND , 20 (2) 160 - 163.

Barron-Casella, EA; Nebbia, G; Rogers, OC; King, KE; Kickler, TS; Casella, JF; (1999) Construction of a human platelet alloantigen-1a epitope(s) within murine glycoprotein IIIa: Identification of residues critical to the conformation of the antibody binding site(s). BLOOD , 93 (9) pp. 2959-2967.

Bellantuono, I; Gao, L; Elsaesser, A; Marley, S; Gordon, M; Goldman, J; Stauss, H; (1999) Selective elimination of leukemic progenitors by allorestricted CTL specific for Wilms tumor antigen-1 (WT-1). BLOOD , 94 (10) 532A - 533A.

Bennett, JM; Kaye, S; Berry, N; Tedder, RS; (1999) A quantitative PCR method for the assay of HIV-1 provirus load in peripheral blood mononuclear cells. J VIROL METHODS , 83 (1-2) 11 - 20.

Billington, OJ; McHugh, TD; Gillespie, SH; (1999) Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. ANTIMICROB AGENTS CH , 43 (8) 1866 - 1869.

Boshoff, C; Weiss, RA; (1999) HHV8/KSHV - Introduction. SEMIN CANCER BIOL , 9 (3) 149 - 150.

Boshoff, C; Weiss, RA; (1999) Introduction. Semin Cancer Biol , 9 (3) pp. 149-150. 10.1006/scbi.1999.0120.

Boulougouris, G; McLeod, JD; Patel, YI; Ellwood, CN; Walker, LS; Sansom, DM; (1999) IL-2-independent activation and proliferation in human T cells induced by CD28. J Immunol , 163 (4) pp. 1809-1816.

Bowen, EF; Cherrington, JM; Lamy, PD; Griffiths, PD; Johnson, MA; Emery, VC; (1999) Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy. J MED VIROL , 58 (4) 402 - 407.

Brown, SC; Fassati, A; Popplewell, L; Page, AM; Henry, MD; Campbell, KP; Dickson, G; (1999) Dystrophic phenotype induced in vitro by antibody blockade of muscle alpha-dystroglycan-laminin interaction. J CELL SCI , 112 (2) 209 - 216.

Buchler, NE; Goldstein, RA; (1999) Effect of alphabet size and foldability requirements on protein structure designability. Proteins , 34 (1) pp. 113-124.

Buchler, NEG; Goldstein, RA; (1999) Universal correlation between energy gap and foldability for the random energy model and lattice proteins. JOURNAL OF CHEMICAL PHYSICS , 111 (14) pp. 6599-6609. 10.1063/1.479951.

Buckley, CD; Pilling, D; Henriquez, NV; Parsonage, G; Threlfall, K; Scheel-Toellner, D; Simmons, DL; (1999) RGD peptides induce apoptosis by direct caspase-3 activation. Nature , 397 (6719) pp. 534-539. 10.1038/17409.

C

Chakrabarti, S; Steven, N; Collingham, K; Cassellas, SA; Pillay, D; Kaur, N; Hale, G; (1999) Viral reactivation and immune reconstitution following Campath 1H and fludarabine based non-myeloablative conditioning for allogeneic stem cell transplantation compared to Campath-based T cell depletion regimens: A preliminary report. BLOOD , 94 (10) 153A - 153A.

Chaudri, ZN; Bartlet-Jones, M; Panayotou, G; Klonisch, T; Roitt, IM; Lund, T; Delves, PJ; (1999) Dual specificity antibodies using a double-stranded oligonucleotide bridge. FEBS LETT , 450 (1-2) 23 - 26.

Chaudri, ZN; Bartlet-Jones, M; Panaytou, G; Klonisch, T; Roitt, IM; Lund, T; Delves, PJ; (1999) Dual specificity antibodies using an oligonucleotide bridge. FEBS Letters , 450 pp. 23-26.

Chern, IF; Steer, JA; Wilson, APR; (1999) Effect of teicoplanin on isolation of Staphylococcus aureus from blood culture media. J ANTIMICROB CHEMOTH , 43 (4) 589 - 591.

Craig, PJ; Beattie, RE; Folly, EA; Banerjee, MD; Reeves, MB; Priestley, JV; Carney, SL; (1999) Distribution of the voltage-dependent calcium channel alpha1G subunit mRNA and protein throughout the mature rat brain. Eur J Neurosci , 11 (8) pp. 2949-2964.

Crawley, E; Isenberg, D; Woo, P; Kay, R; Chi, CM; Chak, SL; Lanchbury, JS; (1999) Interleukin-10 promoter polymorphism and lupus nephritis: Comment on the article by Mok et al [6] (multiple letters). Arthritis and Rheumatism , 42 (3) pp. 590-593.

Crawley, E; Kay, R; Sillibourne, J; Patel, P; Hutchinson, I; Woo, P; (1999) Polymorphic haplotypes of the interleukin-10 5 ' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. ARTHRITIS RHEUM , 42 (6) 1101 - 1108.

Crawley, E; Woo, P; (1999) Cytokines in children with arthritis. Clinical Immunology Newsletter , 19 (10) 105, cont. 112-118.

Crawley, E; Woo, P; Isenberg, DA; (1999) Single nucleotide polymorphic haplotypes of the interleukin-10 5 ' flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus. ARTHRITIS RHEUM , 42 (9) 2017 - 2018.

D

Day, JH; Williams, IG; Zumla, A; Miller, RF; (1999) Protection from Pneumocystis carinii pneumonia. SEX TRANSM INFECT , 75 (3) 202 - 203.

Deayton, J; Mocroft, A; Wilson, P; Emery, VC; Johnson, MA; Griffiths, PD; (1999) Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy. AIDS , 13 (10) 1203 - 1206.

Delves, PJ; (1999) 10th International Congress of Immunology, New Delhi 1st-6th November 1998. (Immunology News. 6,20-21 ).

Delves, PJ; (1999) Antibody fusion proteins. SM Chamov and A Ashkenzi. Wiley-Liss. 6, 239. 34-.

Delves, PJ; (1999) How did AIDS arise? Trans-Caucasian Journal of Immunology , 1 48.-.

Dixon, GL; Heyderman, RS; Kotovicz, K; Jack, DL; Andersen, SR; Vogel, U; Frosch, M; (1999) Endothelial adhesion molecule expression and its inhibition by recombinant bactericidal/permeability-increasing protein are influenced by the capsulation and lipooligosaccharide structure of Neisseria meningitidis. Infect Immun , 67 (11) pp. 5626-5633.

Donoghue, HD; Neild, GH; Street, S; (1999) Presence of Tropheryma whippelii-specific DNA in saliva from healthy individuals. In: J DENT RES. (pp. 1038 - 1038). AMER ASSOC DENTAL RESEARCH

Donoghue, HD; Uberlaker, DH; Spigelman, M; (1999) The use of palaeomicrobiological techniques in a current forensic case. In: Pälfi, G and Dutour, O and Deák, J and Hutás, I, (eds.) Tuberculosis Past and Present. (pp. 363-368). Golden BookPublisher Ldt., Tuberculosis Foundation: Budapest.

Dupin, N; Fisher, C; Kellam, P; Ariad, S; Tulliez, M; Franck, N; van Marck, E; (1999) Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. P NATL ACAD SCI USA , 96 (8) 4546 - 4551.

Dupin, N; Fisher, C; Kellam, P; Ariad, S; Tulliez, M; Franck, N; vanMarck, E; (1999) Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proceedings of the National Academy of Sciences of the United States of America , 96 4546 - 4551.

E

Efstathiou, S; Field, HJ; Griffiths, PD; Kern, ER; Sacks, SL; Sawtell, NM; Stanberry, LR; (1999) Herpes simplex virus latency and nucleoside analogues. ANTIVIR RES , 41 (3) 85 - 100.

Emery, VC; Atkins, MC; Bowen, EF; Clark, DA; Johnson, MA; Kidd, IM; McLaughlin, JE; (1999) Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: Evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6. J MED VIROL , 57 (3) 278 - 282.

Emery, VC; Cope, AV; Bowen, EF; Gor, D; Griffiths, PD; (1999) The dynamics of human cytomegalovirus replication in vivo. J EXP MED , 190 (2) 177 - 182.

Emery, VC; Sabin, C; Feinberg, JE; Grywacz, M; Knight, S; Griffiths, PD; (1999) Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. J Infect Dis , 180 (3) pp. 695-701. 10.1086/314936.

Emery, VC; Sabin, C; Feinberg, JE; Grywacz, M; Knight, S; Griffiths, PD; AIDS Clinical Trials Grp 204, ; (1999) Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: Baseline CMV load dictates time to disease and survival. J INFECT DIS , 180 (3) 695 - 701.

Enjuanes, L; Sola, I; Izeta, A; Sanchez-Morgado, JM; Gonzalez, JM; Alonso, S; Escors, D; (1999) Interference with virus and bacteria replication by the tissue specific expression of antibodies and interfering molecules. MECHANISMS IN THE PATHOGENESIS OF ENTERIC DISEASES 2 , 473 31 - 45.

F

Faint, JM; Pilling, D; Akbar, AN; Kitas, GD; Bacon, PA; Salmon, M; (1999) Quantitative flow cytometry for the analysis of T cell receptor V beta chain expression. J IMMUNOL METHODS , 225 (1-2) 53 - 60.

Farrington, M; Tedder, R; Kibbler, C; Wreghitt, T; Gould, K; Tremlett, CH; (1999) Pre-transplantation testing: who, when and why? J Hosp Infect , 43 Sup S243-S252.

Fassati, A; Goff, SP; (1999) Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. J VIROL , 73 (11) 8919 - 8925.

Fritsche, J; Stonehouse, TJ; Katz, DR; Andreesen, R; Kreutz, M; (1999) Expression of vitamin D-receptor and retinoid receptors during human monocyte differentiation in vitro. J LEUKOCYTE BIOL p. 13.

Fritsche, J; Stonehouse, TJ; Katz, DR; Andreesen, R; Kreutz, M; (1999) Expression of vitamin D-receptor and retinoid receptors during human monocyte differentiation in vitro. BLOOD , 94 (10) 40B-40B.

G

GARSON, JA; Kerr, J; (1999) New viruses and diseases of the human central nervous system. In: Weiss, RA and Dalgleish, A, (eds.) HIV and the New Viruses. Academic Press

GAUDIN, P; MOUTET, F; TUKE, PW; GARSON, JA; (1999) Absence of human retrovirus 5 in French patients with rheumatoid arthritis. Arthritis and Rheumatism , 42 (11) pp. 2492-2494.

Gabunia, K; Roshupkina, T; Kardava, L; Ghirdaladze, D; Isova, G; Jewell, AP; Lydyard, PM; (1999) Decreased function of polymorphonuclear cells in B-chronic lymphocytic leukaemia is related to high white blood cell count. Blood , 94 (10, Su) 40b-40b.

Gao, LQ; Yang, TH; Tourdot, S; Sadovnikova, E; Hasserjian, R; Stauss, HJ; (1999) Allo-major histocompatibility complex-restricted cytotoxic T lymphocytes engraft in bone marrow transplant recipients without causing graft-versus-host disease. BLOOD , 94 (9) 2999 - 3006.

Gao, Y; Xue, S; Griffin, BE; (1999) Sensitivity of an epstein-barr virus-positive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript. Molecular and Cellular Biology , 19 (11) pp. 7305-7313.

Garson, JA; Lubach, D; Passas, J; Whitby, K; Grant, PR; (1999) Suramin blocks hepatitis C binding to human hepatoma cells in vitro. J MED VIROL , 57 (3) 238 - 242.

Gaudin, P; Moutet, F; Tuke, PW; Garson, JA; (1999) Absence of human retrovirus 5 in French patients with rheumatoid arthritis: comment on the article by Griffiths et al. ARTHRITIS RHEUM , 42 (11) 2492 - 2493.

Gilson, RJC; Chopra, KB; Newell, AM; Murray-Lyon, IM; Nelson, MR; Rice, SJ; Tedder, RS; (1999) A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection. J VIRAL HEPATITIS , 6 (5) 387 - 395.

Goebel, FD; Mannhalter, JW; Belshe, RB; Eibl, MM; Grob, PJ; de Gruttolae, V; Griffiths, PD; (1999) Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. AIDS , 13 (12) 1461 - 1468.

Govindarajan, S; Recabarren, R; Goldstein, RA; (1999) Estimating the total number of protein folds. Proteins , 35 (4) pp. 408-414.

Grange, J; Zumla, A; (1999) Tuberculosis and the poverty-disease cycle. J ROY SOC MED , 92 (3) 105 - 107.

Grange, J; Zumla, A; (1999) Tuberculosis and the poverty-disease cycle [editorial]. Journal of the Royal Society of Medicine , 92 (3) pp. 105-107.

Grange, JM; Zumla, A; (1999) Paradox of the global emergency of tuberculosis. LANCET , 353 (9157) 996 - 996.

Griffiths, PD; (1999) Defending vaccines from the enemy within. Rev Med Virol , 9 (3) pp. 145-146.

Griffiths, PD; (1999) Destruction of smallpox stocks. Rev Med Virol , 9 (4) pp. 217-218.

Griffiths, PD; Ait-Khaled, M; Bearcroft, CP; Clark, DA; Quaglia, A; Davies, SE; Burroughs, AK; (1999) Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirus. JOURNAL OF MEDICAL VIROLOGY , 59 (4) 496 - 501.

Griffiths, PD; Cope, AV; Hassan-Walker, AF; Emery, VC; (1999) Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation. Transpl Infect Dis , 1 (3) pp. 179-186.

Grimbacher, B; Dutra, AS; Holland, SM; Fischer, RE; Pao, M; Gallin, JI; Puck, JM; (1999) Analphoid marker chromosome in a patient with hyper-IgE syndrome, autism, and mild mental retardation. GENET MED , 1 (5) 213 - 218.

Grimbacher, B; Holland, SM; Gallin, JI; Greenberg, F; Hill, SC; Malech, HL; Miller, JA; (1999) Hyper-IgE syndrome with recurrent infections - An autosomal dominant multisystem disorder. NEW ENGL J MED , 340 (9) 692 - 702.

Grimbacher, B; Holland, SM; Puck, JM; (1999) Hyper-IgE syndrome - Reply. NEW ENGL J MED , 341 (5) 376 - 377.

Grimbacher, B; Schaffer, AA; Holland, SM; Davis, J; Gallin, JI; Malech, HL; Atkinson, TP; (1999) Genetic linkage of hyper-IgE syndrome to chromosome 4. AM J HUM GENET , 65 (3) 735 - 744.

Grzywacz, M; Deayton, JR; Bowen, EF; Wilson, P; Emery, VC; Johnson, MA; Griffiths, PD; (1999) Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients. J MED VIROL , 59 (3) 323 - 328.

H

Harries, AD; (1999) The tuberculosis pandemic: implications for health in the tropics. Trans R Soc Trop Med Hyg , 93 (6) pp. 678-679.

Harwood, CA; McGregor, JM; Proby, CM; Breuer, J; (1999) Human papillomavirus and the development of non-melanoma skin cancer. J CLIN PATHOL , 52 (4) 249 - 253.

Harwood, CA; Spink, PJ; Surentheran, T; Leigh, IM; de Villiers, EM; McGregor, JM; Proby, CM; (1999) Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J CLIN MICROBIOL , 37 (11) 3545 - 3555.

Hassan-Walker, AF; Kidd, IM; Sabin, C; Sweny, P; Griffiths, PD; Emery, VC; (1999) Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: Relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG). J MED VIROL , 58 (2) 182 - 187.

Hawrami, K; Breuer, J; (1999) Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus. J VIROL METHODS , 79 (1) 33 - 40.

Heyderman, RS; Ison, CA; Peakman, M; Levin, M; Klein, NJ; (1999) Neutrophil response to Neisseria meningitidis: inhibition of adhesion molecule expression and phagocytosis by recombinant bactericidal/permeability-increasing protein (rBPI21). J Infect Dis , 179 (5) pp. 1288-1292. 10.1086/314706.

Hoen, B; Kinloch, S; Janossy, G; Cooper, D; Phillips, A; Perrin, L; Sonnerborg, A; (1999) Preliminary results: Quadruple HAART (ZDV/3TC/Abacavir/Amprenavir) initiated during primary HIV infection (PHI) is associated with a sharp viremia decrease and increase in CD4 response. Presented at: 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, USA.

Hunt, DM; Sahota, VK; Taylor, K; Simrak, D; Hornigold, N; Arnemann, J; Wolfe, J; (1999) Clustered cadherin genes: A sequence-ready contig for the desmosomal cadherin locus on human chromosome 18. GENOMICS , 62 (3) pp. 445-455.

I

Isenberg, D; Crawley, E; Woo, P; (1999) Neuropsychiatric systemic lupus erythematosus [letter]. Annals of the Rheumatic Diseases , 58 (10) pp. 658-659.

Ison, CA; Anwar, N; Cole, MJ; Galassini, R; Heyderman, RS; Klein, NJ; West, J; (1999) Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay. Microb Pathog , 27 (4) pp. 207-214. 10.1006/mpat.1999.0296.

J

James, DG; Zumla, A; (1999) The granulomatous disorders. [Book]. Cambridge Univ Pr

Jeddi, P; Keusch, J; Lydyard, PM; Bodman-Smith, KB; Chesnutt, MS; Wofsy, D; Hirota, H; (1999) The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G. IMMUNOLOGY , 98 (3) 475 - 480.

Johnson, RW; Dworkin, RH; Breuer, J; (1999) Untitled. EUR J PAIN , 3 (4) 297 - 299.

Jäger, U; Takeuchi, Y; Porter, C; (1999) Induction of complement attack on human cells by Gal(alpha1,3)Gal xenoantigen expression as a gene therapy approach to cancer. Gene Therapy , 6 (6) pp. 1073-1083.

K

Kellam, P; (1999) Emerging viruses: their diseases and identification. In: AIDS and the New Viruses. (pp. 521-537). Academic Press

Kellam, P; Bourboulia, D; Dupin, N; Shotton, C; Fisher, C; Talbot, S; Boshoff, C; (1999) Characterisation of monoclonal antibodies raised against against the latent nuclear antigen (LNA) of human herpesvirus 8. Journal of Virology , 73 pp. 5149-5155.

Kellam, P; Bourboulia, D; Dupin, N; Shotton, C; Fisher, C; Talbot, S; Boshoff, C; (1999) Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8. J VIROL , 73 (6) 5149 - 5155.

Kemeny, DM; Vyas, B; Vukmanovic-Stejic, M; Thomas, MJ; Noble, A; Loh, LC; O'Connor, BJ; (1999) CD8(+) T cell subsets and chronic obstructive pulmonary disease. AM J RESP CRIT CARE , 160 (5) S33 - S37.

Kibbler, CC; (1999) Antifungal prophylaxis with itraconazole oral solution in neutropenic patients. MYCOSES , 42 pp. 121-124.

Kibbler, CC; (1999) Infections in solid organ transplant recipients. Curr Top Pathol , 92 pp. 19-35.

Kibbler, CC; Prentice, HG; (1999) Pathogen 'shift' in febrile neutropenia. CURR OPIN INFECT DIS , 12 (4) pp. 351-354.

King, DS; Amjadi, P; Tilling, RS; Kinloch-de Loes, S; Loveday, C; Johnson, MA; Janossy, G; (1999) "Naive" and "memory" CD4+ T cells and T-cell receptor (TCR) Vbeta repertoire dynamics are independent of the levels of viremia following HIV seroconversion. Immunological Letters , 66 pp. 199-206.

Kinloch, S; (1999) Early intervention including seroconversion and during primary HIV infection. Presented at: AIDS Treatment Project. ,, London.

Kinloch, S; Janossy, G; Phillips, A; Perrin, L; Hoen, B; Cooper, D; Sonnerborg, A; (1999) HAART (3TC/ZDV/abacavir/Amprenavir) during primary HIV infection (PHI) is associated with a sharp viremia decline and increase in IL-2 synthetic capacity. Presented at: Seventh European Conference on Clinical Aspects and Treatment of HIV infection, Lisbon, Portugal.

Kipling, D; Wynford-Thomas, D; Jones, CJ; Akbar, A; Aspinall, R; Bacchetti, S; Blasco, MA; (1999) Telomere-dependent senescence. Nat Biotechnol , 17 (4) pp. 313-314. 10.1038/7827.

Knowles, WA; Pillay, D; Johnson, MA; Hand, JF; Brown, DWG; (1999) Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J MED VIROL , 59 (4) 474 - 479.

Koshi, JM; Mindell, DP; Goldstein, RA; (1999) Using physical-chemistry-based substitution models in phylogenetic analyses of HIV-1 subtypes. Mol Biol Evol , 16 (2) pp. 173-179.

Kvirkvelia, N; Free, P; Lund, T; Roitt, IM; Delves, PJ; (1999) Differential effects on lymphocyte cell lines of supernatants from short term cultures of human placenta. In: (pp. 13-).

L

Labrecque, LG; Xue, SA; Kazembe, P; Phillips, J; Lampert, I; Wedderburn, N; Griffin, BE; (1999) Expression of Epstein-Barr virus lytically related genes in African Burkitt's lymphoma: correlation with patient response to therapy. International Journal of Cancer , 81 (1) pp. 6-11.

Lang, J; Zuckerman, JN; Clarke, P; Barrett, P; Kirkpatrick, C; Wood, S; (1999) Comparison of the immunogenicity and safety of two 17D yellow fever vaccines: results of a randomised equivalence trial in adults. American Journal of Tropical Medicine and Hygiene , 60 (6) pp. 1045-1050.

Lawlor, E; Power, J; Garson, JA; Yap, PL; Davidson, F; Columb, G; Smith, D; (1999) Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation. VOX SANG , 76 (3) 138 - 143.

Laylor, R; Porakishvili, N; De Souza, JB; Playfair, JHL; Delves, PJ; Lund, T; (1999) DNA vaccination favours memory rather than effector B cell responses. CLIN EXP IMMUNOL , 117 (1) 106 - 112.

Leirisalo-Repo, M; Hernandez-Munoz, HE; Rook, GAW; (1999) Agalactosyl IgG is elevated in patients with active spondyloarthropathy. RHEUMATOL INT , 18 (5-6) 171 - 176.

Lopes, LM; Hughson, E; Anstee, Q; O'Neil, D; Katz, DR; Chain, BM; (1999) Vectorial function of major histocompatibility complex class II in a human intestinal cell line. IMMUNOLOGY , 98 (1) 16 - 26.

Low, W; Smith, A; Ashworth, A; Collins, M; (1999) JNK activation is not required for Fas-mediated apoptosis. ONCOGENE , 18 (25) pp. 3737-3741.

Low, W; Smith, A; Ashworth, A; Collins, M; (1999) JNK activation is not required for Fas-mediated apoptosis. Oncogene , 18 (25) pp. 3737-3741. 10.1038/sj.onc.1202702.

Lydyard, PM; Jewell, AP; Jamin, C; Youinou, P; (1999) CD5 B cells and B-cell malignancies. Current Opinion in Hematology , 6 pp. 30-36.

M

Mackay, AD; Taylor, MB; Kibbler, CC; Hamilton-Miller, JM; (1999) Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect , 5 (5) pp. 290-292.

Madge, S; Kinloch-de-Loes, S; Mercey, D; Johnson, MA; Weller, IVD; (1999) Lipodystrophy in patients naive to HIV protease inhibitors. AIDS , 13 (6) 735 - 737.

Mageed, RA; Vencovsky, P; Youinou, P; Lydyard, PM; (1999) Polyreactivity and immunoglobulin variable region gene usage in human CD5+ B cells. Trans-Caucasian Journal of Immunology , 1

Maini, MK; Boni, C; Ogg, GS; King, AS; Reignat, S; Lee, CK; Larrubia, JR; (1999) Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. GASTROENTEROLOGY , 117 (6) 1386 - 1396.

Maini, MK; Casorati, G; Dellabona, P; Wack, A; Beverley, PCL; (1999) T-cell clonality in immune responses. IMMUNOL TODAY , 20 (6) 262 - 266.

Maini, MK; Soares, MVD; Zilch, CF; Akbar, AN; Beverley, PCL; (1999) Telomerase upregulation in an acute viral infection: a mechanism to maintain line replicative capacity of CD8+ T cells undergoing clonal expansion. The Journal of Immunology , 162 pp. 4521-4526.

Maini, MK; Soares, MVD; Zilch, CF; Akbar, AN; Beverley, PCL; (1999) Virus-induced CD8(+) T cell clonal expansion is associated with telomerase up-regulation and telomere length preservation: A mechanism for rescue from replicative senescence. J IMMUNOL , 162 (8) 4521 - 4526.

Maraveyas, A; Baban, B; Kennard, D; Rook, GAW; Westby, M; Grange, JM; Lydyard, P; (1999) Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes. ANN ONCOL , 10 (7) 817 - 824.

Marcinkiewicz, J; Nowak, B; Grabowska, A; Bobek, M; Petrovska, L; Chain, B; (1999) Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidase-halide system. Immunology , 98 (3) pp. 371-378.

Martin, F; Neil, S; Kupsch, J; Maurice, M; Cosset, F; Collins, M; (1999) Retrovirus targeting by tropism restriction to melanoma cells. J Virol , 73 (8) pp. 6923-6929.

Maurice, M; Mazur, S; Bullough, FJ; Salvetti, A; Collins, MKL; Russell, SJ; Cosset, FL; (1999) Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelopes glycoproteins. BLOOD , 94 (2) 401 - 410.

Maurice, M; Mazur, S; Bullough, FJ; Salvetti, A; Collins, MKL; Russell, SJ; Cossett, F; (1999) Efficient gene delivery to quiescent IL2-dependent cells by MLV-derived vectors harboring IL2 chimeric envelope glycoproteins. Blood , 94 p. 410.

McDermott, A; Cohen, SBA; Zuckerman, JN; Madrigal, JA; (1999) Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine. Vaccine , 17 pp. 330-339.

McDermott, AB; Madrigal, JA; Sabin, CA; Zuckerman, JN; Cohen, SB; (1999) The influence of host factors and immunogenetics on lymphocyte responses to Hepagene vaccination. Vaccine , 17 (11-12) pp. 1329-1337.

McDermott, AB; Madrigal, JA; Sabin, CA; Zuckerman, JN; Cohen, SBA; (1999) The influence of host factors upon lymphocyte response to Hepagene vaccination. Vaccine , 17 pp. 1329-1337.

Mocroft, A; Barry, S; Sabin, CA; Lepri, AC; Kinloch, S; Drinkwater, A; Lipman, M; (1999) The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. AIDS , 13 (10) 1255 - 1261.

Mocroft, A; Barry, S; Sabin, CA; Lepri, AC; Kinloch, S; Drinkwater, A; Lipman, M; (1999) The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. AIDS , 13 (10) pp. 1255-1261.

Mota, F; Calder, V; Rutault, K; Singer, A; Chain, B; (1999) Characterization of soluble factors from cultures of premalignant cervical epithelium. Eur J Gynaecol Oncol , 20 (4) pp. 262-267.

Mota, F; Rayment, N; Chong, S; Singer, A; Chain, B; (1999) The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin Exp Immunol , 116 (1) pp. 33-40.

Mulatero, C; Surentheran, T; Breuer, J; Rudd, RM; (1999) Simian virus 40 and human pleural mesothelioma. THORAX , 54 (1) 60 - 61.

N

Noble, A; Vyas, B; Vukmanovic-Stejic, M; Kemeny, DM; (1999) Regulation of Tc1/Tc2 and Th1/Th2 subset commitment by altered peptides and TcR-mediated signaling events. FASEB J , 13 (5) A939 - A939.

O

O'Neil, D; Swanton, C; Jones, A; Medd, PG; Rayment, N; Chain, B; (1999) IFN-gamma down-regulates MHC expression and antigen processing in a human B cell line. J IMMUNOL , 162 (2) pp. 791-798.

Onyebujoh, PC; Levin, JB; Fourie, FB; Garhiram, V; Tembe, LC; Phili, NP; Mthiyane, TCP; (1999) Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. LANCET , 354 (9173) 116 - 119.

P

PREISER, W; AYLIFFE, U; KAYE, S; GARSON, JA; BRINK, NS; TEDDER, RS; (1999) UNSPECIFIED Presented at: Development of a fully controlled quantitative cytomegalovirus (HCMV) DNA PCR. 3rd Annual Meeting of the European Society for Clinical Virology. Budapest.

Palmer, K; Moore, J; Everard, M; Harris, JD; Rodgers, S; Rees, RC; Murray, AK; (1999) Gene therapy with autologous, interleukin-2-secreting tumour cells in patients with malignant melanoma increases circulating anti-tumour cytotoxic T lymphocytes. Human Gene Therapy , 10 pp. 1261-1268.

Pap, I; Józsa, L; Repa, I; Bajzik, G; Lakhani, SR; Donoghue, HD; Spigelman, M; (1999) 18-19th century tuberculosis in naturally mummified individuals (Vác, Hungary). In: Pälfi, G and Dutour, O and Deák, J and Hutás, I, (eds.) Tuberculosis Past and Present. (pp. 421-428). Golden Book Publisher Ltd., Tuberculosis Foundation: Budapest.

Pawson, R; Potter, M; Geretti, AM; Griffiths, P; Prentice, HG; (1999) Combined foscarnet and ganciclovir at half doses for the pre-emptive treatment of CMV infection: A pilot study. BRIT J HAEMATOL , 105 59 - 59.

Peters, MJ; Dixon, G; Kotowicz, KT; Hatch, DJ; Heyderman, RS; Klein, NJ; (1999) Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. BRIT J HAEMATOL , 106 (2) 391 - 399.

Pilling, D; Akbar, AN; Girdlestone, J; Orteu, CH; Borthwick, NJ; Amft, N; Scheel-Toellner, C; (1999) Interferon-beta is the principal mediator of stromal cell rescue of T cells from apoptosis. European Journal of Immunology , 29 pp. 1041-1050.

Pilling, D; Akbar, AN; Girdlestone, J; Orteu, CH; Borthwick, NJ; Amft, N; Scheel-Toellner, D; (1999) Interferon-beta mediates stromal cell rescue of T cells from apoptosis. EUR J IMMUNOL , 29 (3) 1041 - 1050.

Pizzato, M; Marlow, SA; Blair, ED; Takeuchi, Y; (1999) Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J VIROL , 73 (10) 8599 - 8611.

Porakishvili, N; Dalla Chiesa, M; Lund, T; Delves, PJ; Roitt, IM; (1999) Dramatically decreased cross-reactivity with human leuteinizing hormone of a mutant molecule of human chorionic gonadatropin beta chain. In: (pp. 81-).

Porakishvili, N; Kulikova, N; Elliott, S; Jewell, AP; Patterson, K; Yong, K; Pers, J; (1999) Apoptosis of leukaemic cells in patients with B-chronic lymphocytic leukaemia (B-CLL) induced by the ligation of CD5. Blood , 94 (10, Su) 313b-313b.

Porakishvili, N; Roshupkina, T; Jewell, AJ; Patterson, K; Yong, K; Lydyard, PM; (1999) Perforin and serine esterase-expressing circulating CD4+ cells are present in patients with B-chronic lymphocytic leukaemia (B-CLL). Blood , 10 (Suppl) 437a-437a.

Porakishvili, N; Roshupkina, T; Jewell, AP; Patterson, K; Yong, K; Lydyard, PM; (1999) Circulating CD4+ cells in patients with B-chronic lymphocytic leukaemia (B-CLL) express perforin (PF) and serine esterase (SE). Immunology , 98 (Suppl) 20-.

Prentice, HG; Kibbler, CC; (1999) Liposomal amphotericin B for fever and neutropenia. NEW ENGL J MED , 341 (15) pp. 1152-1153.

Prentice, HG; Moore, J; Potter, M; Herbert, L; Kibbler, C; Scarffe, H; Poynton, C; (1999) GM-CSF may have a role in the management of invasive aspergillosis (1A) in the neutropenic patient. BRITISH JOURNAL OF HAEMATOLOGY , 105 p. 62.

R

Racz, P; Tenner-Racz, K; Andersson, J; Gazzard, B; Kinloch, S; Stellbrink, H; Staszewski, S; (1999) HIV-1 associated lymph node changes during primary HIV infection (PHI). Presented at: Seventh European Conference on Clinical Aspects and Treatment of HIV infection, Lisbon, Portugal.

Rayment, NB; Haven, AJ; Madden, B; Murday, A; Trickey, R; Shipley, M; Davies, MJ; (1999) Myocyte loss in chronic heart failure. J PATHOL , 188 (2) 213 - 219.

Rickman, L; Simrak, D; Stevens, HP; Hunt, DM; King, IA; Bryant, SP; Eady, RAJ; (1999) N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. HUM MOL GENET , 8 (6) pp. 971-976.

Rook, GAW; (1999) Glucocorticoids and immune function. BEST PRACT RES CL EN , 13 (4) 567 - 581.

Rook, GAW; Baker, R; (1999) Cortisol metabolism, cortisol sensitivity and the pathogenesis of leprosy reactions. TROP MED INT HEALTH , 4 (7) 493 - 498.

Rook, GAW; Stanford, JL; (1999) Skin-test responses to mycobacteria in atopy and asthma. ALLERGY , 54 (3) 285 - 286.

Rutault, K; Alderman, C; Chain, BM; Katz, DR; (1999) Reactive oxygen species activate human peripheral blood dendritic cells. FREE RADICAL BIO MED , 26 (1-2) 232 - 238.

S

SALDANHA, J; LELIE, N; HEATH, A; GARSON, JA; (1999) Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. Vox Sanguinis , 76 pp. 149-158.

Sabin, CA; Clewley, GS; Deayton, JR; Mocroft, A; Johnson, MA; Lee, CA; McLaughlin, JE; (1999) Shorter survival in HIV-positive patients with diarrhoea who excrete adenovirus from the GI tract. J Med Virol , 58 (3) pp. 280-285.

Scheel-Toellner, D; Pilling, D; Akbar, AN; Hardie, D; Lombardi, G; Salmon, M; Lord, JM; (1999) Inhibition of T cell apoptosis by IFN-beta rapidly reverses nuclear translocation of protein kinase C-delta. EUR J IMMUNOL , 29 (8) 2603 - 2612.

Seah, GT; Rook, GAW; (1999) A sensitive, non-radioactive quantitative method for measuring IL-4 and IL-4 delta 2 mRNA in unstimulated cells from multiple clinical samples, using nested RT-PCR. J IMMUNOL METHODS , 228 (1-2) 139 - 149.

Smith, DB; Lawlor, E; Power, J; O'Riordan, J; McAllister, J; Lycett, C; Davidson, F; (1999) A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland. VOX SANG , 76 (3) 175 - 180.

Smith, NA; Sabin, CA; Gopal, R; Bourboulia, D; Labbet, W; Boshoff, C; Barlow, D; (1999) Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. JOURNAL OF INFECTIOUS DISEASES , 180 (3) 600 - 606.

Speidel, K; Samady, L; Ledermann, JA; Chain, BM; Coffin, R; Katz, D; (1999) Development of transfected dendritic cells for immunotherapy of ovarian cancer. BRIT J CANCER , 80 21 - 21.

Spigelman, M; Donoghue, HD; (1999) Mycobacterium tuberculosis DNA in archaeological specimens'. In: Pälfi, G and Dutour, O and Deák, J and Hutás, I, (eds.) Tuberculosis Past and Present. (pp. 353-360). Golden Book Publisher Ltd., Tuberculosis Foundation: Budapest.

Stauss, HJ; (1999) Immunotherapy with CTLs restricted by nonself MHC. IMMUNOL TODAY , 20 (4) 180 - 183.

Stonehouse, TJ; Woodhead, VE; Herridge, PS; Ashrafian, H; George, M; Chain, BM; Katz, DR; (1999) Molecular characterization of U937-dependent T-cell co-stimulation. IMMUNOLOGY , 96 (1) 35 - 47.

Street, S; Donoghue, HD; Neild, GH; (1999) Tropheryma whippelii DNA in saliva of healthy people. LANCET , 354 (9185) 1178 - 1179.

Subhani, JM; Kibbler, C; Dooley, JS; (1999) Antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). ALIMENT PHARM THER , 13 (2) pp. 103-116.

Subhani, JM; Kibbler, C; Dooley, JS; (1999) Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther , 13 (2) pp. 103-116.

T

Taams, LS; Poulter, LW; Rustin, MHA; Akbar, AN; (1999) Phenotypic analysis of IL-10-treated macrophages using the monoclonal antibodies RFD1 and RFD7. PATHOBIOLOGY , 67 (5-6) 249 - 252.

Tailor, CS; Nouri, A; Zhao, Y; Takeuchi, Y; Kabat, D; (1999) A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. Journal of Virology , 73 (5336) pp. 4470-4474.

Takeuchi, Y; (1999) [Retroviral pseudotypes]. Uirusu , 49 (1) pp. 11-18.

Talbot, SJ; Weiss, RA; Kellam, P; Boshoff, C; (1999) Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. VIROLOGY , 257 (1) 84 - 94.

Tatla, S; Woodhead, V; Foreman, JC; Chain, BM; (1999) The role of reactive oxygen species in triggering proliferation and IL-2 secretion in T cells. FREE RADICAL BIO MED , 26 (1-2) 14 - 24.

Tessier, D; Steffen, R; Gamble, K; Zuckerman, JN; Sikand, V; Kain, K; Keystone, J; (1999) Travelling Healthy: Current trends in travel medicine. Presented at: Proceedings of the 6th International Conference on Travel Medicine, Montreal, Canada, June 1999..

Thrasher, AJ; Burns, S; (1999) Wiskott-Aldrich syndrome: a disorder of haematopoietic cytoskeletal regulation. Microsc Res Tech , 47 (2) pp. 107-113. 10.1002/(SICI)1097-0029(19991015)47:2<107::AID-JEMT3>3.0.CO;2-H.

Towers, GJ; Stockholm, D; Labrousse-Najburg, V; Carlier, F; Danos, O; Pagès, JC; (1999) One step screening of retroviral producer clones by real time quantitative PCR. J Gene Med , 1 (5) pp. 352-359. 10.1002/(SICI)1521-2254(199909/10)1:5<352::AID-JGM57>3.0.CO;2-I.

V

Vanhems, P; Dassa, C; Lambert, J; Cooper, DA; Perrin, L; Vizzard, J; Hirschel, B; (1999) Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology , 21 pp. 99-106.

Vella, C; King, D; Zheng, NN; Fickenscher, H; Breuer, J; Daniels, RS; (1999) Alterations in the V1/V2 domain of HIV-2(CBL24) glycoprotein 105 correlate with an extended cell tropism. AIDS RES HUM RETROV , 15 (15) 1399 - 1402.

Vyas, B; Vukmanovic-Stejic, M; Noble, A; Kemeny, DM; (1999) IL-4 inhibits human CD8 T cell expression of the common IL-2 receptor gamma chain. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , 118 (2-4) pp. 433-436.

W

Waddell, RD; von Reyn, CF; Baboo, KS; Mwinga, A; Chintu, C; Zumla, A; (1999) The effects of BCG immunization and human immunodeficiency virus infection on dual skin test reactions to purified protein derivative and Mycobacterium avium sensitin among adults in Zambia. INT J TUBERC LUNG D , 3 (3) 255 - 260.

Walker, LS; McLeod, JD; Boulougouris, G; Patel, YI; Ellwood, CN; Hall, ND; Sansom, DM; (1999) Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signalling. Immunology , 98 (4) pp. 569-575.

Wedderburn, LR; Maini, MK; Patel, A; Beverley, PCL; Woo, P; (1999) Molecular fingerprinting reveals non-overlapping T cell oligoclonality between an inflamed site and peripheral blood. INT IMMUNOL , 11 (4) 535 - 543.

Wedderburn, LR; Murray, KJ; Linch, D; Woo, P; (1999) Molecular analysis of TCR diversity before and after autologus stem cell transplantation for polyarteritis nodosa. Ann.Rheum.Dis. (Suppl.) p. 331.

Wedderburn, LR; Patel, A; Robinson, N; Varsani, H; Woo, P; (1999) T cells from the inflamed joints of children with juvenile idiopathic arthritis show a marked skew towards a Th1 phenotype as assessed by intracellular cytokine analysis and chemokine receptor expression. Ann.Rheum.Dis. (Suppl.) p. 322.

Wedderburn, LR; Patel, A; Varsani, H; Woo, P; (1999) T cell receptor repertoire of healthy young children and adults shows a wide variation in the degree of CD8+ oligoclonality and correlation with CD57hi and CD28lo cells. Immunology , 98 (Suppl.) p. 123.

Wedderburn, LR; Woo, P; (1999) Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis. SPRINGER SEMIN IMMUN , 21 (3) 361 - 374.

Weiss, RA; (1999) Biomedicine - Xenografts and retroviruses. SCIENCE , 285 (5431) 1221 - 1222.

Weiss, RA; (1999) Viruses, cancer and aids. FEMS IMMUNOL MED MIC , 26 (3-4) 227 - 232.

Weiss, RA; (1999) Xenografts and retroviruses. Science , 285 (5431) pp. 1221-1222.

Weiss, RA; (1999) The river - A journey to the source of HIV and AIDS. SCIENCE , 286 (5443) 1305 - 1306.

Weiss, RA; Griffiths, D; Takeuchi, Y; Patience, C; Venables, PJW; (1999) Retroviruses: ancient and modern. ARCH VIROL 171 - 177.

Weiss, RA; Wrangham, RW; (1999) From Pan to pandemic. NATURE , 397 (6718) 385 - 386.

Whitcup, SM; Fortin, E; Lindblad, AS; Griffiths, P; Metcalf, JA; Robinson, MR; Manischewitz, J; (1999) Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. JAMA-J AM MED ASSOC , 282 (17) 1633 - 1637.

Wilson, AP; Bint, AJ; Glenny, AM; Leibovici, L; Peto, TE; (1999) Meta-analysis and systematic review of antibiotic trials. Journal of Hospital Infection , 43 (Suppl) S211-S214.

Wilson, APR; (1999) Antibiotics in treatment and prevention of surgical infection. Presented at: 3rd General Surgery Week.

Wilson, APR; (1999) Emerging antimicrobial resistance in the surgical compromised host. J CHEMOTHERAPY , 11 (6) 518 - 523.

Wilson, APR; (1999) Therapeutic possibilities: present and future. Presented at: 1st International Symposium on Antimicrobial Resistance Focus on Glycopeptide Resistance in Gram-positive cocci..

Wilson, APR; (1999) Chapter 3.9: Endocarditis: Pathophysiology and causes, Prevention, Treatment. Chapter 13.2.3: Antimicrobial selection policies. Chapter 17.1.8. Antimicrobials. In: Webb, AR and Shapiro, MJ and Singer, M and Suter, PM, (eds.) Oxford Textbook of Critical Care. (249,876,12-260,878,12). Oxford University Press: Oxford.

Wilson, APR; Brent, D; Beckett, G; (1999) Bench-top sterilizers and CSSD. Journal of Hospital Infection , 43 pp. 246-247.

Woo, P; (1999) Amyloidosis. In: McMillan, JA and De Angelis, CD and Feigin, RD and Warshaw, JB, (eds.) Oski's Pediatrics: Principles and Practices. (2175-). Lippincott, Williams and Wilkins: Philadelphia.

Woo, P; Martin, K; (1999) Juvenile idiopathic arthritis. In: Isenberg, D and Miller, JJ, (eds.) Adolescent Rheumatology. (pp. 71-94). Martin Dunitz: London.

Z

Zanghellini, F; Boppana, SB; Emery, VC; Griffiths, PD; Pass, RF; (1999) Asymptomatic primary cytomegalovirus infection: Virologic and immunologic features. In: JOURNAL OF INFECTIOUS DISEASES. (pp. 702 - 707). UNIV CHICAGO PRESS

Zuckerman, AJ; Zuckerman, JN; (1999) Molecular epidemiology of hepatitis B virus mutants - Commentary. J MED VIROL , 58 (3) 193 - 195.

Zuckerman, AJ; Zuckerman, JN; (1999) Molecular epidemiology of hepatitis B virus mutants. J Med Virol , 58 (3) pp. 193-195.

Zuckerman, JN; (1999) Imported tropical respiratory tract infections. Current Opinion in Infectious Diseases , 5 (3) pp. 164-167.

Zuckerman, JN; (1999) New recombinant hepatitis B DNA vaccines. DRUG NEWS PERSPECT , 12 (8) 473 - 476.

Zuckerman, JN; (1999) Vaccines, children and travelling. Vaccines: Children and Practice , 2 (12) 14-.

Zuckerman, JN; Zuckerman, AJ; (1999) Hepatitis viruses. In: Infectious Diseases. Mosby International

Zuckerman, JN; Zuckerman, AJ; (1999) Epidemiology of hepatitis B. In: Lee, WM, (ed.) Clinics in Liver Disease, Hepatitis B Virus Infection. (pp. 179-187). Philadelphia: WB Saunders

Zumla, A; Grange, JM; (1999) Doing something about tuberculosis. BRIT MED J , 318 (7189) 956 - 956.

Zumla, A; Mwaba, P; Squire, SB; Grange, JM; (1999) The tuberculosis pandemic - Which way now? J INFECTION , 38 (2) 74 - 79.

Zumla, A; Squire, SB; Chintu, C; Grange, JM; (1999) The tuberculosis pandemic: Implications for health in the tropics. International Journal of Leprosy and Other Mycobacterial Diseases , 67 (4 SUPP) pp. 529-530.

Zumla, A; Squire, SB; Chintu, C; Grange, JM; (1999) The tuberculosis pandemic: implications for health in the tropics. T ROY SOC TROP MED H , 93 (2) 113 - 117.

Zumla, A; Squire, SB; Chintu, C; Grange, JM; (1999) The tuberculosis pandemic: implications for health in the tropics: a reply. T ROY SOC TROP MED H , 93 (6) 678 - 679.

This list was generated on Sun Aug 21 10:51:51 2016 BST.